CD44 and breast carcinoma: Lei et al. (2016) performed transcriptome sequencing on BCSCs, breast cancer cells, mammary cells and CD44+ mammary cells and found that carbonic anhydrase 12 (CA12) was a prognostic biomarker in HER2-positive breast cancer [57].